rs1721082
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_019851.3(FGF20):c.*449T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.695 in 151,650 control chromosomes in the GnomAD database, including 37,848 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.69 ( 37789 hom., cov: 30)
Exomes 𝑓: 0.68 ( 59 hom. )
Consequence
FGF20
NM_019851.3 3_prime_UTR
NM_019851.3 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.127
Publications
2 publications found
Genes affected
FGF20 (HGNC:3677): (fibroblast growth factor 20) The protein encoded by this gene is a member of the fibroblast growth factor family. The fibroblast growth factors possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This gene product is a secreted neurotrophic factor but lacks a typical signal peptide. It is expressed in normal brain, particularly the cerebellum, and may regulate central nervous system development and function. Homodimerization of this protein was shown to regulate its receptor binding activity and concentration gradient in the extracellular matrix. Genetic variations of this gene have been associated with Parkinson disease susceptibility. [provided by RefSeq, Oct 2009]
FGF20 Gene-Disease associations (from GenCC):
- bilateral renal agenesisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- renal hypodysplasia/aplasia 2Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.779 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FGF20 | NM_019851.3 | c.*449T>A | 3_prime_UTR_variant | Exon 3 of 3 | ENST00000180166.6 | NP_062825.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FGF20 | ENST00000180166.6 | c.*449T>A | 3_prime_UTR_variant | Exon 3 of 3 | 1 | NM_019851.3 | ENSP00000180166.5 |
Frequencies
GnomAD3 genomes AF: 0.695 AC: 105126AN: 151316Hom.: 37774 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
105126
AN:
151316
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.680 AC: 151AN: 222Hom.: 59 Cov.: 0 AF XY: 0.650 AC XY: 78AN XY: 120 show subpopulations
GnomAD4 exome
AF:
AC:
151
AN:
222
Hom.:
Cov.:
0
AF XY:
AC XY:
78
AN XY:
120
show subpopulations
African (AFR)
AF:
AC:
2
AN:
6
American (AMR)
AF:
AC:
7
AN:
14
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
2
East Asian (EAS)
AF:
AC:
2
AN:
6
South Asian (SAS)
AF:
AC:
4
AN:
6
European-Finnish (FIN)
AF:
AC:
7
AN:
8
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
126
AN:
174
Other (OTH)
AF:
AC:
2
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.695 AC: 105177AN: 151428Hom.: 37789 Cov.: 30 AF XY: 0.699 AC XY: 51712AN XY: 74006 show subpopulations
GnomAD4 genome
AF:
AC:
105177
AN:
151428
Hom.:
Cov.:
30
AF XY:
AC XY:
51712
AN XY:
74006
show subpopulations
African (AFR)
AF:
AC:
21231
AN:
41332
American (AMR)
AF:
AC:
10403
AN:
15210
Ashkenazi Jewish (ASJ)
AF:
AC:
2843
AN:
3468
East Asian (EAS)
AF:
AC:
2641
AN:
5162
South Asian (SAS)
AF:
AC:
3471
AN:
4806
European-Finnish (FIN)
AF:
AC:
8888
AN:
10266
Middle Eastern (MID)
AF:
AC:
218
AN:
294
European-Non Finnish (NFE)
AF:
AC:
53247
AN:
67876
Other (OTH)
AF:
AC:
1469
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1495
2990
4485
5980
7475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
820
1640
2460
3280
4100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.